Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer. Salari K, Kowitz J, Twum-Ampofo J, et al. Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer. Urologic oncology. 2023. doi:10.1016/j.urolonc.2023.04.018 Read more